This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Companion Animal Specialty Drugs Market

Pet Humanizations Trends to Foment Demand for Companion Animals Specialty Drugs. Here’s More Analysis with Focus on Key Countries Including US, UK, Brazil, Germany, Mexico, and France.

Companion Animal Specialty Drugs Market by Product, Distribution Channel & region - Forecast 2022 - 2032

A Summary of the Companion Animal Specialty Drugs Market Development

[341 Pages Report] The global companion animal specialty drugs market is projected to have a moderate-paced CAGR of 4.21% during the forecast period. The current valuation of the market is US$ 37,624.67 Million in 2022. The market value of the companion animal specialty drugs market is anticipated to reach a high of US$ 56,828.56 Million by the year 2032. A historical CAGR of 5.42% has been recorded by the experts of Future Market Insights for the concerned market. This growth is supported by:

  • Rising adoption of pet animals due to growing urbanization and the increase in the number of nuclear families is among the primary market growth factors.
  • Growing focus on animal health along with surging demand for pet insurance especially in developed countries will augment the market expansion for companion animal specialty drugs.
  • Consistent rise in the number of diseases is generating demand for companion animal drugs.
  • Industrial growth can likely be attributed to increasing incidences of zoonotic and food-borne diseases.
  • Rising per capita income enables the urban populace to increasingly spend on the treatment of companion animals with diagnosis, vaccines, mitigation, and treatment of diseases like kidney concerns, heartworm, Lyme disease, and more, thereby surging the market share for companion animal specialty drugs.

Although the market is projected to register healthy growth across the estimated study period, it has been revealed by the expert analysts at FMI that certain constraints still prevail in the burgeoning forum. A number of elements were identified while analyzing the market that is likely to hinder the advancement of the companion animal specialty drugs market. They are as follows:

  • Risks or chances of side effects, such as mild vomiting, exist after the intake of a drug if it is not suited or administered in excess amounts acts as a key restraint in the global market.
  • There is a very high cost associated with companion animals’ specialty drugs, and the middle-class population with pets in low-income countries still remains unaware of such advanced treatments.

Therefore, it is projected that a lack of awareness is likely to curb the penetration of these drugs across certain regions, simultaneously impeding the growth of the concerned market.

Customize this Report

Let us know your requirement to get
100% FREE customization

Launch of New Veterinary Drug Products – A Blessing to Boon

As per the analysis of FMI, there is an unprecedented surge witnessed by the global companion animal specialty drugs market, owing to rising ownership of animals and increasing demand for animal-derived products.

New veterinary drugs are being launched in recent years, and the ones identified to gain rapid traction are parasiticides. This drug segment accounted for a market share of 32.2% in the base year. The rising prominence of parasiticides through the forecast period can be attributed to the fact that there is an upsurge in demand for animals and animal-derived products like meat, and the administration of parasiticides enable to boost the quality of meat for consumption and is most sincerely improving the efficiency of livestock and health of companion animals.

At present, technological advances are being made in the administering of this newly launched specialty drug parasiticide such as collars, sprays, and dips, which in turn is expected to boost the market size of companion animal specialty drugs through the projection period.

Report Attribute

Details

Companion Animal Specialty Drugs Market Value (2022)

US$ 37,624.67 Million

Companion Animal Specialty Drugs Market Anticipated Value (2032)

US$ 56,828.56 Million

Companion Animal Specialty Drugs Projected Growth Rate (2022-2032)

4.21%

A Contrast with the Historical Market Scenario

The global market for companion animal specialty drugs generated huge demand in previous years. The forum registered a gradual CAGR of 5.42% during the period 2017-2021. A number of factors are responsible for this substantial growth.

The expert analysts at FMI have analyzed that the development and approval of new drugs for the treatment of animal diseases is spurring the demand for companion animal specialty drugs. It is identified while studying the market in-details that the rising prevalence of obesity amongst pet dogs and other companion animals has resulted in higher sales of anti-obesity drugs.

Furthermore, significant growth in the number of animal healthcare and NGOs in recent years is also a key aspect majorly contributing to the acceleration of the companion animal specialty drugs. Moreover, some pet diseases also cause serious effects on humans and need to be mitigated for the prevention of infection, which is further identified to boost the market size of companion animal specialty drugs.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Comparative Analysis of Adjacent Markets

Companion Animals Specialty Drugs Market:

Differentiating Aspects

Companion Animals Specialty Drugs Market

CAGR

5.8%

Market Valuation in 2022

US$ 37,624.67 Billion

Projected Market Value in 2032

US$ 56,828.56 Billion

Drivers

  • Increase in the e-pet humanization trend is expected to jig up the dynamics of the companion animal specialty drugs market.
  • Rising awareness about disease prevention coupled with pet insurance is a key factor contributing to the expansion of the forum.

Veterinary Medicine Market:

Differentiating Aspects

Veterinary Medicine Market

CAGR

4.6%

Market Valuation in 2022

US$ 26,291.34 Million

Projected Market Value in 2032

US$ 41,222.05 Million

Drivers

  • Rise in the number of pet owners and surge in livestock population across the globe is likely to spur demand in the forthcoming years.
  •  Surge in the prevalence of various medical conditions in animals is fueling the growth of the veterinary medicine market through the forecast period.

Over-the-Counter Veterinary Drugs Market:

Differentiating Aspects

Over-the-Counter Veterinary Drugs Market

CAGR

8.1%

Market Valuation in 2022

US$ 8.32 Billion

Projected Market Value in 2032

US$ 18.14 Billion

Drivers

  • Launch of numerous innovative veterinary medications over the past few years has given various options for the doctors and consumers to choose the best medication for their pets.
  • Drugs made especially for treating specific disorders in animals are gaining traction amongst pet owners as well as farm animal owners. 

Category-wise Insights – Identifying the Domineering Segments

Vaccines – By Product Type

The vaccines segment accounted for more than US$ 2.89 billion in the base year. The surging market valuation of this product type can be attributed to:

  • Increasing research and development activities in regard to the development of curable vaccines for companion animals is stimulating segment growth.
  • Owing to increased R&D, the market has witnessed the emergence of new technologies including recombinant DNA vaccines for dogs in companion animal drugs, thereby fuelling the industry expansion. This type of vaccine is reckoned to provide enhanced disease prevention to pet animals.

Online Veterinary Pharmacies – By Distribution Channel

Technological advances are reported in every sector including animal health, thereby driving the market progression. This segment is anticipated to account for a market share of 37.8% through the forecast period, advancing at a CAGR of 6.8%. The reasons augmenting the growth of this segment are as follows:

  • Increasing inclination toward mobile apps that help in tracking animal health habits, and nutritional intake, as well as alerts for pet care services, are likely to foster the market revenue.
  • Veterinary online pharmacies provide pet care products, supplements, vaccinations, injections, drugs, and many more, and the ease of availability is a key reason for expanding market shares.
  • Integration of digital platforms in veterinary care and the population preference shift towards online services will accelerate the overall market demand.
  • High acceptance of e-commerce platforms in emerging economies is also identified to assist in business revenue growth.

Oral Consumption – By Route of Administration

The oral segment accounted for a market valuation of US$ 2.86 billion in the base year. This route of administration is identified to lead through the forecast period due to:

  • Increasing preference for companion animals and their ease of consuming specialty drugs.
  • Various benefits associated with oral animal drugs such as the reduced risk of acquiring infections, less pain, and requiring no skin penetration support demand for oral dosage.
  • Suspensions, solutions, capsules, as well as tablet forms of drugs, are administrated orally in companion animals to improve their health conditions and production.
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Regional Insights                                               

Strategic Initiatives Coupled with Rising Digitalization Stir Up the Regional Landscapes

Country/Region United States
Statistics

The U.S. companion animal specialty drugs market dominated the global forum in the base year, with more than 88% of revenue shares in the North American region.

It is estimated that around 44% of households in the U.S. have a dog and nearly 33% have a cat.

Key Propellants

The market in the U.S is poised to accrue significant gains owing to factors as follows:

  • The rising adoption of pets across the country has improved the sales of companion animal specialty drugs.
  • Internet is the primary source and with the rising penetration of social media, millennials and baby boomers are taking extra care of their pet well-being in this country.
Country/Region Brazil
Statistics The market size for companion animal specialty drugs in Brazil accounted for a valuation of US$ 426 million in the base year.
Key Propellants

The factors owing to the rapid progression of the market in Brazil are as follows:

  • Availability of better health infrastructure, stringent regulatory guidelines for animal healthcare, and increased spending on R&D initiatives are predicted to propel the companion animal specialty drugs forum.
  • High acceptance rate of pet animals is driving the industry value and is estimated to create lucrative opportunities in the forthcoming years.
Country/Region Germany
Statistics

Germany is projected to advance at a CAGR of 2.4% through the forecast period.

The industry profit margin in Germany has increased over the past five years and is expected to have steady growth during the period 2022-2032.

Key Propellants

The market dynamics in Germany are fuelled by the following aspects:

  • Initiatives are being undertaken to lower the obesity rate of companion animals, which is fueling the growth of the companion animal specialty drugs market in Germany.
  • There is a spike in demand for companion animals, coupled with the rising number of healthcare NGOs, and animal hospitals further bolstering the market outlook for the country.

Start-up Ecosystem

How are the New Entrants Ceding a Silver Lining to the Forum?

The start-up companies in the companion animal specialty drugs market are continually innovating the drug for better curing the companion animals, paying keen attention to faster recovery. The business models are changing due to evolving market dynamics and the start-up firms are in tandem with the pet humanization trends of the populace, investing heavily in common veterinary drugs.

5 Top Start-ups to Watch For

Wiggles

Funding: US$ 9 Million

This firm is a provider of a wide range of veterinary care products and services. The company provides pet-focused supplements, foods, medicines, and ayurvedic and herbal care products. In addition to selling its products online, the company also provides vet on-call and grooming services.

FidoCure

Funding: US$ 16 Million

Online platform offering health care services for dogs. It connects pet owners and vets. It sends the tumor sample from the original biopsy used to diagnose cancer for DNA sequencing. It identifies genomic mutations and suggests targeted therapy. The vet provides the treatment based on the suggestion given on the platform.

Itch

Funding: US$ 16 Million

Itchpet has developed customized flea treatment products. The user can provide the details via the platform to develop a customized flea and tick treatment product. The products developed are flea, calm, dental, warmer, joint, and ear.

PetMedix

Funding: US$ 37 Million

Developer of monoclonal antibody therapeutics for pets. The company has developed Ky9 and Felyne platforms to generate therapeutic antibodies to treat cancer, inflammation, and other conditions

Nexvet

Funding: US$ 38 Million

Nexvet is focussed on developing novel therapies for companion animal care. Its proprietary PETization platform allows for rapid translation of monoclonal antibodies between species. Current focus is on chronic pain and inflammatory diseases in cats and dogs. Pipeline products include NV-01 for chronic associated with osteoarthritis in dogs, NV-02 for chronic pain in cats and NV-08 targeting inflammation and atopic dermatitis in dogs.

Competitive Landscape

Strong Industry Players Revolutionize & Upscale the Market-o-nomics

The global companion animal specialty drugs market is growing rapidly due to the presence of prominent key players as well as start-ups. Most companies are implementing new strategies for the development of innovative companion animal specialty drugs that cause fewer side effects. Consequently, these factors are anticipated to drive the global companion animal drugs market.

Leaders are focusing on new product launches and adopting inorganic growth strategies to remain competitive and sustain in the market. Partnerships with other players are enhancing product offerings, thus helping the companies to increase their customer base by providing superior quality products.

Recent Developments

  • In February 2021, Vetoquinol acquired Canadian rights for the Profender product family from Elanco Animal Health. The acquisition is poised to impact the company’s revenue and offer business development opportunities in untapped economies.
  • In August 2020, Elanco Animal Health Incorporated announced that it has acquired Bayer Animal Health. The transaction was valued at USD 6.89 billion. This development helped the company to expand itself in the durable animal health industry.
  • In January 2021, Merck Animal Health, known as MSD Animal Health outside the U.S. and Canada, a division of Merck & Co. Inc., announced the collaboration with the Street Dog Coalition to offer medications, vaccines, and treatment for pets of those experiencing homelessness.
  • In June 2021, ALR Technologies SG Pvt. Ltd., the diabetes management company announced the establishment of its new business division which will be the world’s first and only CGM for diabetic companion animals, known as ‘ALRT Animal Health Division.
  • In 2017, Zoetis emerged as a leading player with the highest share of compassion animal specialty drugs, as the company has a considerable and significant market presence, a diverse portfolio of product offerings, and an acute strategic perspective which includes M&As, such as the acquisition of Abaxis in 2018.

Some of the key companies proliferating in the market are:

  • Merck Animal Health (Merck & Co., Inc.)
  • Boehringer Ingelheim International GmbH.
  • Elanco Animal Health Incorporated
  • Virbac S.A.
  • Biogenesis Bago SA
  • Piramal Group
  • Zoetis
  • NEOGEN Corporation.
  • Vetoquinol S.A.
  • Ceva Santé Animale

Key Segments in the Companion Animal Specialty Drugs Market

By Product:

  • Antibiotics
  • Anti-Inflammatory Drugs
  • Parasiticides
  • Heartworm
  • Behavioral Products
  • Nutritional Products
  • Anti-Obesity Drugs
  • Skin Care Products
  • Vaccines

By Distribution Channel:

  • Modern Trade
  • Online Distribution
  • Neighborhood Stores
  • Other Retail Format

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

The companion animal specialty drugs market is likely to record a CAGR of 4.21% through 2032.

The companion animal specialty drugs market is currently valued at US$ 37, 624.67 Mn in 2022.

The companion animal specialty drugs market has the potential to reach a valuation of US$ 56,828.56 Mn by 2032.

Demand for vaccines is predicted to remain the highest.

Consumers prefer online veterinary pharmacies to purchase companion animal specialty drugs.

Table of Content

1. Executive Summary

2. Market Introduction

    2.1. Market Definition

    2.2. Market Taxonomy

3. Global Companion Animal Drugs Market Analysis Scenario

    3.1. Market Size (US$ Mn) and Forecast

    3.2. Market Size and Y-o-Y Growth

4. Market Dynamics  

    4.1. Drivers

    4.2. Restraints

    4.3. Opportunity

    4.4. Global Trends

    4.5. PEST Analysis - U.S.

    4.6. PEST Analysis - Europe

    4.7. Portor's Five Analysis

    4.8. Trilateral regulatory harmonization between U.S., EU and Japan on registration of veterinary products

5. Global Companion Animal Drugs Market Analysis and Forecasts, By Product Type

    5.1. Introduction

    5.2. Basis Point Share (BPS) Analysis By Product Type

    5.3. Y-o-Y Growth Projections By Product Type

    5.4. Market Value Forecast By Product Type, 2021–2031

        5.4.1. Antibiotics

        5.4.2. Anti-inflammatory Drugs

        5.4.3. Parasiticides

        5.4.4. Heartworm

        5.4.5. Behavioral Products

        5.4.6. Nutritional Products

        5.4.7. Anti-Obesity Drugs

        5.4.8. Skin Care Products

        5.4.9. Vaccines

    5.5. Market Attractiveness By Product Type

6. Global Companion Animal Drugs Market Analysis and Forecasts, By Distribution Channel

    6.1. Introduction

    6.2. Basis Point Share (BPS) Analysis By Distribution Channel

    6.3. Y-o-Y Growth Projections By Distribution Channel

    6.4. Market Value Forecast By Distribution Channel, 2021–2031

        6.4.1. Veterinary Hospitals

        6.4.2. Veterinary Clinics

        6.4.3. Pharmacies and Drug Stores

    6.5. Market Attractiveness By Distribution Channel

7. Global Companion Animal Drugs Market Analysis and Forecasts, By Region

    7.1. Basis Point Share (BPS) Analysis By Region

    7.2. Y-o-Y Growth Projections By Region

    7.3. Market Value Forecast By Region

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. APEJ

        7.3.6. Japan

        7.3.7. MEA

    7.4. Market Attractiveness By Region

8. North America Companion Animal Drugs Market Analysis and Forecast

    8.1. Introduction

        8.1.1. Basis Point Share (BPS) Analysis By Country

        8.1.2. Y-o-Y Growth Projections By Country

    8.2. Market Value Forecast By Product Type, 2021–2031

        8.2.1. Antibiotics

        8.2.2. Anti-inflammatory Drugs

        8.2.3. Parasiticides

        8.2.4. Heartworm

        8.2.5. Behavioral Products

        8.2.6. Nutritional Products

        8.2.7. Anti-Obesity Drugs

        8.2.8. Skin Care Products

        8.2.9. Vaccines

    8.3. Market Value Forecast By Distribution Channel, 2021–2031

        8.3.1. Veterinary Hospitals

        8.3.2. Veterinary Clinics

        8.3.3. Pharmacies and Drug Stores

    8.4. Market Value Forecast By Country, 2021–2031

        8.4.1. U.S.

        8.4.2. Canada

    8.5. Market Attractiveness Analysis

        8.5.1. By Product Type

        8.5.2. By Distribution Channel

        8.5.3. By Country

    8.6. Regional Trends

    8.7. Drivers and Restraints: Impact Analysis

9. Latin America Companion Animal Drugs Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Basis Point Share (BPS) Analysis By Country

        9.1.2. Y-o-Y Growth Projections By Country

    9.2. Market Value Forecast By Product Type, 2021–2031

        9.2.1. Antibiotics

        9.2.2. Anti-inflammatory Drugs

        9.2.3. Parasiticides

        9.2.4. Heartworm

        9.2.5. Behavioral Products

        9.2.6. Nutritional Products

        9.2.7. Anti-Obesity Drugs

        9.2.8. Skin Care Products

        9.2.9. Vaccines

    9.3. Market Value Forecast By Distribution Channel, 2021–2031

        9.3.1. Veterinary Hospitals

        9.3.2. Veterinary Clinics

        9.3.3. Pharmacies and Drug Stores

    9.4. Market Value Forecast By Country, 2021–2031

        9.4.1. Brazil

        9.4.2. Mexico

        9.4.3. Argentina

        9.4.4. Rest of Latin America

    9.5. Market Attractiveness Analysis

        9.5.1. By Product Type

        9.5.2. By Distribution Channel

        9.5.3. By Country

    9.6. Regional Trends

    9.7. Drivers and Restraints: Impact Analysis

10. Western Europe Companion Animal Drugs Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Basis Point Share (BPS) Analysis By Country

        10.1.2. Y-o-Y Growth Projections By Country

    10.2. Market Value Forecast By Product Type, 2021–2031

        10.2.1. Antibiotics

        10.2.2. Anti-inflammatory Drugs

        10.2.3. Parasiticides

        10.2.4. Heartworm

        10.2.5. Behavioral Products

        10.2.6. Nutritional Products

        10.2.7. Anti-Obesity Drugs

        10.2.8. Skin Care Products

        10.2.9. Vaccines

    10.3. Market Value Forecast By Distribution Channel, 2021–2031

        10.3.1. Veterinary Hospitals

        10.3.2. Veterinary Clinics

        10.3.3. Pharmacies and Drug Stores

    10.4. Market Value Forecast By Country, 2021–2031

        10.4.1. U.K.

        10.4.2. Germany

        10.4.3. France

        10.4.4. Italy

        10.4.5. Spain

        10.4.6. Nordics

        10.4.7. Benelux

        10.4.8. Rest of Western Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Product Type

        10.5.2. By Distribution Channel

        10.5.3. By Country

    10.6. Regional Trends

    10.7. Drivers and Restraints: Impact Analysis

11. Eastern Europe Companion Animal Drugs Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Basis Point Share (BPS) Analysis By Country

        11.1.2. Y-o-Y Growth Projections By Country

    11.2. Market Value Forecast By Product Type, 2021–2031

        11.2.1. Antibiotics

        11.2.2. Anti-inflammatory Drugs

        11.2.3. Parasiticides

        11.2.4. Heartworm

        11.2.5. Behavioral Products

        11.2.6. Nutritional Products

        11.2.7. Anti-Obesity Drugs

        11.2.8. Skin Care Products

        11.2.9. Vaccines

    11.3. Market Value Forecast By Distribution Channel, 2021–2031

        11.3.1. Veterinary Hospitals

        11.3.2. Veterinary Clinics

        11.3.3. Pharmacies and Drug Stores

    11.4. Market Value Forecast By Country, 2021–2031

        11.4.1. Russia

        11.4.2. Poland

        11.4.3. Rest of Eastern Europe

    11.5. Market Attractiveness Analysis

        11.5.1. By Product Type

        11.5.2. By Distribution Channel

        11.5.3. By Country

    11.6. Regional Trends

    11.7. Drivers and Restraints: Impact Analysis

12. APEJ Companion Animal Drugs Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Basis Point Share (BPS) Analysis By Country

        12.1.2. Y-o-Y Growth Projections By Country

    12.2. Market Value Forecast By Product Type, 2021–2031

        12.2.1. Antibiotics

        12.2.2. Anti-inflammatory Drugs

        12.2.3. Parasiticides

        12.2.4. Heartworm

        12.2.5. Behavioral Products

        12.2.6. Nutritional Products

        12.2.7. Anti-Obesity Drugs

        12.2.8. Skin Care Products

        12.2.9. Vaccines

    12.3. Market Value Forecast By Distribution Channel, 2021–2031

        12.3.1. Veterinary Hospitals

        12.3.2. Veterinary Clinics

        12.3.3. Pharmacies and Drug Stores

    12.4. Market Value Forecast By Country, 2021–2031

        12.4.1. China

        12.4.2. India

        12.4.3. Australia & New Zealand

        12.4.4. ASEAN

        12.4.5. Rest of APEJ

    12.5. Market Attractiveness Analysis

        12.5.1. By Product Type

        12.5.2. By Distribution Channel

        12.5.3. By Country

    12.6. Regional Trends

    12.7. Drivers and Restraints: Impact Analysis

13. Japan Companion Animal Drugs Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Absolute $ Opportunity (US$ Mn), 2021–2031

    13.2. Market Value Forecast By Product Type, 2021–2031

        13.2.1. Antibiotics

        13.2.2. Anti-inflammatory Drugs

        13.2.3. Parasiticides

        13.2.4. Heartworm

        13.2.5. Behavioral Products

        13.2.6. Nutritional Products

        13.2.7. Anti-Obesity Drugs

        13.2.8. Skin Care Products

        13.2.9. Vaccines

    13.3. Market Value Forecast By Distribution Channel, 2021–2031

        13.3.1. Veterinary Hospitals

        13.3.2. Veterinary Clinics

        13.3.3. Pharmacies and Drug Stores

    13.4. Market Attractiveness Analysis

        13.4.1. By Product Type

        13.4.2. By Distribution Channel

    13.5. Regional Trends

    13.6. Drivers and Restraints: Impact Analysis

14. MEA Companion Animal Drugs Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Basis Point Share (BPS) Analysis By Country

        14.1.2. Y-o-Y Growth Projections By Country

    14.2. Market Value Forecast By Product Type, 2021–2031

        14.2.1. Antibiotics

        14.2.2. Anti-inflammatory Drugs

        14.2.3. Parasiticides

        14.2.4. Heartworm

        14.2.5. Behavioral Products

        14.2.6. Nutritional Products

        14.2.7. Anti-Obesity Drugs

        14.2.8. Skin Care Products

        14.2.9. Vaccines

    14.3. Market Value Forecast By Distribution Channel, 2021–2031

        14.3.1. Veterinary Hospitals

        14.3.2. Veterinary Clinics

        14.3.3. Pharmacies and Drug Stores

    14.4. Market Value Forecast By Country, 2021–2031

        14.4.1. GCC Countries

        14.4.2. South Africa

        14.4.3. Rest of MEA

    14.5. Market Attractiveness Analysis

        14.5.1. By Product Type

        14.5.2. By Distribution Channel

        14.5.3. By Country

    14.6. Regional Trends

    14.7. Drivers and Restraints: Impact Analysis

15. Competition Landscape

    15.1. Competition Dashboard

    15.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments and SWOT Analysis)

        15.2.1. Zoetis, Inc.

            15.2.1.1. Overview

            15.2.1.2. Financials

            15.2.1.3. Strategy

            15.2.1.4. Recent Developments and SWOT Analysis

        15.2.2. Merck and Co., Inc.

            15.2.2.1. Overview

            15.2.2.2. Financials

            15.2.2.3. Strategy

            15.2.2.4. Recent Developments and SWOT Analysis

        15.2.3. Bayer AG

            15.2.3.1. Overview

            15.2.3.2. Financials

            15.2.3.3. Strategy

            15.2.3.4. Recent Developments and SWOT Analysis

        15.2.4. Elanco

            15.2.4.1. Overview

            15.2.4.2. Financials

            15.2.4.3. Strategy

            15.2.4.4. Recent Developments and SWOT Analysis

        15.2.5. Boehringer Ingelheim Animal Health

            15.2.5.1. Overview

            15.2.5.2. Financials

            15.2.5.3. Strategy

            15.2.5.4. Recent Developments and SWOT Analysis

        15.2.6. Ceva Santé Animale

            15.2.6.1. Overview

            15.2.6.2. Financials

            15.2.6.3. Strategy

            15.2.6.4. Recent Developments and SWOT Analysis

16. Assumptions and Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product Type, 2022 - 2032

Table 02: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032

Table 03: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Region, 2022 - 2032

Table 04: North America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2022 - 2032

Table 05: North America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2022 - 2032

Table 06: North America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032

Table 07: Latin America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2022 - 2032

Table 08: Latin America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2022 - 2032

Table 09: Latin America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032

Table 10: Western Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2022 - 2032

Table 11: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2022 - 2032

Table 12: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032

Table 13: Eastern Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2022 - 2032

Table 14: Eastern Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2022 - 2032

Table 15: Eastern Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032

Table 16: APEJ Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2022 - 2032

Table 17: APEJ Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2022 - 2032

Table 18: APEJ Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032

Table 19 : Japan Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast, 2022 - 2032

Table 20: Japan Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2022 - 2032

Table 21: Japan Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032

Table 22: MEA Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2022 - 2032

Table 23: MEA Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2022 - 2032

Table 24: MEA Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Companion Animal Drugs Market Size (US$ Mn) By Product Type, 2021 & 2031

Figure 02: Global Companion Animal Drugs Market Share Analysis (%) By Product Type, 2021 & 2031

Figure 03: Global Companion Animal Drugs Market Y-o-Y Growth (%) By Product Type, 2022 - 2032

Figure 04: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Antibiotics Segment, 2022 - 2032

Figure 05: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Anti-inflammatory Drugs Segment, 2022 - 2032

Figure 06: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Parasiticides Segment, 2022 - 2032

Figure 07: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Heartworm Segment, 2022 - 2032

Figure 08: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Behavioral Products Segment, 2022 - 2032

Figure 09: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) Nutritional Products Segment, 2022 - 2032

Figure 10: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Anti-Obesity Drugs Segment, 2022 - 2032

Figure 11: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Skin Care Products Segment, 2022 - 2032

Figure 12: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Vaccines Segment, 2022 - 2032

Figure 13: Global Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032

Figure 14 : Global Companion Animal Drugs Market Size (US$ Mn) By Distribution Channel, 2021 & 2031

Figure 15: Global Companion Animal Drugs Market Share by Distribution Channel, 2022 - 2032

Figure 16: Global Companion Animal Drugs Market Y-o-Y Growth (%) By Distribution Channel, 2022 - 2032

Figure 17: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Veterinary Hospitals Segment, 2022 - 2032

Figure 18: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Veterinary Clinics Segment, 2022 - 2032

Figure 19: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Pharmacies and Drug Stores Segment, 2022 - 2032

Figure 20: Global Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032

Figure 21: Global Companion Animal Drugs Market Size (US$ Mn) By Region, 2021 & 2031

Figure 22: Global Companion Animal Drugs Market Share Analysis (%) By Region, 2021 & 2031

Figure 23: Global Companion Animal Drugs Market Y-o-Y Growth (%) By Region, 2022 - 2032

Figure 24: North America Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 25: Latin America Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 26: Western Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 27: Eastern Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 28: APEJ Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 29: Japan Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 30: MEA Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 31: Global Companion Animal Drugs Market Attractiveness Analysis By Region, 2022 - 2032

Figure 32: North America Companion Animal Drugs Market Share Analysis (%) By Country, 2017 - 2027

Figure 33: North America Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2022 - 2032

Figure 34: The U.S. Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),

Figure 35: Canada Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),

Figure 36: North America Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032

Figure 37: North America Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032

Figure 38: Global Companion Animal Drugs Market Attractiveness Analysis By Country, 2022 - 2032

Figure 39: Latin America Companion Animal Drugs Market Share Analysis (%) By Country, 2022 - 2032

Figure 40: Latin America Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2022 - 2032

Figure 41: Brazil Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 42: Mexico Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 43: Argentina Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 44: Rest of Latin America Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 45: Latin America Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032

Figure 46: Latin America Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032

Figure 47: Latin America Companion Animal Drugs Market Attractiveness Analysis By Country, 2022 - 2032

Figure 48: Western Europe Companion Animal Drugs Market Share Analysis (%) By Country, 2021 & 2031

Figure 49: Western Europe Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2022 - 2032

Figure 50: U.K. Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 51: Germany Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 52: France Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),

Figure 53: Italy Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 54: Spain Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 55: Nordic Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),

Figure 56:  Benelux Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 57: Rest of Western Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 58: Western Europe Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032

Figure 59: Western Europe Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032

Figure 60: Western Europe Companion Animal Drugs Market Attractiveness Analysis By Country, 2022 - 2032

Figure 61: Eastern Europe Companion Animal Drugs Market Share Analysis (%) By Country, 2022 - 2032

Figure 62: Eastern Europe Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2022 - 2032

Figure 63: Russia Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 64: Poland Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 65: Rest of Eastern Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 66: Eastern Europe Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032

Figure 67: Eastern Europe Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032

Figure 68: Eastern Europe Companion Animal Drugs Market Attractiveness Analysis By Country, 2022 - 2032

Figure 69: APEJ Companion Animal Drugs Market Share Analysis (%) By Country, 2017 &  2027

Figure 70: APEJ Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2022 - 2032

Figure 71: China Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 72: India Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 73: A&NZ Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 74: ASEAN Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 75: Rest of APEJ Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 76: APEJ Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032

Figure 77: APEJ Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032

Figure 78: APEJ Companion Animal Drugs Market Attractiveness Analysis By Country, 2022 - 2032

Figure 79: Japan Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 80: Japan Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032

Figure 81: Japan Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032

Figure 82: MEA Companion Animal Drugs Market Share Analysis (%) By Country, 2021 & 2031

Figure 83: MEA Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2022 - 2032

Figure 84: GCC countries Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 85: South Africa Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 86: Rest of MEA Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032

Figure 87: North America Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032

Figure 88: North America Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032

Figure 89: MEA Companion Animal Drugs Market Attractiveness Analysis By Country, 2022 - 2032 

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Injectable Drugs Market

Published : June 2022

Healthcare

Antimetabolite Drugs Market

Published : June 2020

Healthcare

General Anesthesia Drugs Market

Published : August 2015

Google translate

Companion Animal Specialty Drugs Market